Shils M E, Baker H, Frank O
JPEN J Parenter Enteral Nutr. 1985 Mar-Apr;9(2):179-88. doi: 10.1177/0148607185009002179.
Although the AMA-FDA parenteral adult multivitamin formula is now widely used, there are no published data on the efficacy of this formulation in maintaining adequate vitamin nutriture in patients on long-term parenteral nutrition. Blood levels of its constituent nutrients were determined in 16 clinically stable home total parenteral nutrition patients with severe gastrointestinal dysfunction, the majority of whom had been on home total parenteral nutrition for 1 to 9 yr and most of whom were ingesting some food orally. The daily formula (MVI-12) was added to the basic total parenteral nutrition formula in 2-day batches; the vitamins were thus infused approximately 3 hr after preparation on day 1 and after 27 hr on day 2. The duration of infusions was from 8 to 16 hr. Blood was drawn approximately 36 hr after completion of the last vitamin infusion. Plasma, trichloroacetic acid-treated plasma, and whole blood were frozen until analyzed for the vitamins by microbiologic or chemical methods. All vitamin levels, except for vitamin D metabolites, were measured four times in each patient between the 4th and 36th wk while receiving daily MVI-12. Single determinations of 25-OH and 1:25 (OH)2 vitamin D were made in eight of the 16 patients between the 61st and 84th wk while on MVI-12. Repeat values during this extended period were also made on five of the patients for vitamins A and E. These values were compared with serum vitamin levels obtained on an earlier formulation (MVI concentrate, Berocca C, and folate each given twice weekly and B12 given once weekly). The AMA-FDA formula given daily maintained blood levels above the lower normal limits for most of its constituent vitamins and vitamin D metabolites for the great majority of stable home total parenteral nutrition adults with unexplained occasional exceptions. However, almost half of the vitamin A levels and some of the pantothenate and biotin values were above the normal range; these tended to be associated with the presence of renal disease. Ascorbic acid and thiamin levels tended to be clustered in the lower normal range. Because of evidence for loss of ascorbic acid standing in total parenteral nutrition solutions for 24 hr prior to infusion, it is recommended that the vitamin formulation be added to the total parenteral nutrition solution just prior to infusion.
尽管美国医学协会(AMA)-美国食品药品监督管理局(FDA)的肠外成人多种维生素配方目前已被广泛使用,但关于该配方在长期接受肠外营养的患者中维持充足维生素营养状况的疗效,尚无公开数据。对16例临床稳定的重度胃肠功能障碍家庭肠外营养患者的血液中该配方所含营养素水平进行了测定,其中大多数患者已接受家庭肠外营养1至9年,且大多数患者口服摄入一些食物。每日配方(MVI-12)以2天的量分批添加到基础肠外营养配方中;因此,维生素在第1天制备后约3小时输注,第2天在27小时后输注。输注持续时间为8至16小时。在最后一次维生素输注完成后约36小时采集血液。血浆、经三氯乙酸处理的血浆和全血均冷冻保存,直至用微生物学或化学方法分析维生素。在接受每日MVI-12期间,除维生素D代谢产物外,对每位患者的所有维生素水平在第4至36周期间进行了4次测量。在第61至84周期间,对16例患者中的8例进行了25-羟基维生素D和1,25-二羟基维生素D的单次测定,此时患者正在接受MVI-12治疗。在此延长期间,还对5例患者的维生素A和维生素E进行了重复测定。这些值与早期配方(MVI浓缩液、百乐顺C,叶酸每周给药两次,维生素B12每周给药一次)获得的血清维生素水平进行了比较。对于大多数稳定的家庭肠外营养成人患者,每日给予AMA-FDA配方可使大多数所含维生素和维生素D代谢产物的血液水平维持在正常下限以上,仅有一些无法解释的例外情况。然而,几乎一半的维生素A水平以及一些泛酸和生物素值高于正常范围;这些情况往往与肾脏疾病的存在有关。抗坏血酸和硫胺素水平往往集中在正常范围下限。由于有证据表明抗坏血酸在输注前在肠外营养溶液中放置24小时后会损失,建议在即将输注前将维生素配方添加到肠外营养溶液中。